This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order under contract SPE2DX15D3201/SPE2DX24F2P7X awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,259.50 firm fixed-price contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used to treat diabetes. The contract has an ultimate completion date of January 5, 2024. This delivery order is part of Amerisourcebergen's...
This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNEUZ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.74 firm fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The contract has a period of performance through February 11, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award, with an ID of SPE2DB24D1201|SPE2DB25FJAZK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,282.88, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication used to manage diabetes. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,133.91 firm fixed-price delivery order is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a diabetes medication. The contract has an ultimate completion date of May 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the...
This federal contract award, with ID SPE2DB20D2001|SPE2DB24FM80T, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication for diabetes management. The contract has a firm fixed price of $9,124.78 and an ultimate completion date of August 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award, SPE2DB20D3101|SPE2DB24FQUV0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,235.60 firm fixed-price delivery order is for the procurement of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used in the treatment of diabetes. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1047|SPE2DB24FF70U, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which is a delivery order with a firm fixed price, is valued at $11,315.57 and has an ultimate completion date of May 21, 2024. The contract is for the procurement of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product. This contract is not associated with a set-aside program. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,146.23 Firm Fixed Price Delivery Order contract is for the supply of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a medication used for the treatment of diabetes. The contract has an ultimate completion date of January 7, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The $41,797.44 fixed-price delivery order has a completion date of September 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This federal contract award, SPE2DB20D2001|SPE2DB25FPMBW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,133.30 firm fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a medication used for diabetes management. The contract has an ultimate completion date of February 26, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...